• <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 發布時間:2019-08-02 23:22 原文鏈接: HumanFastTrackmRNAIsolation

    Preparation of Cells

    1.Prepare or collect between 2x107 cells for each mRNA prep (will yield about 10-20μg of mRNA). If PBMCs from a whole blood sample are to be used, the sample should be prepared with Ficoll-Paque according to the manufacturer's protocol. The isolated PBMCs can then be used in this protocol.

    2.If cells are adherent, gently agitate and scrape cells from the surface of the flask with a cell scraper to suspend in the media. If cells are non-adherent, proceed to next step.

    3.Place the suspension of cells in a 50ml conical tube, pellet at ~400xg for 5 minutes.

    4.Discard the supernatant, leave the pellet intact.

    5.Freeze the pellet in a dry ice/ethanol bath (or on liquid N2) until solid.

    6.Store at -70℃ until ready for mRNA preparation.

    Modified FastTrack 2.0 Protocol

    Isolation of mRNA

    1.Add 15ml of Lysis Buffer (15ml Stock Buffer + 300 ul RNase/Protein Degrader) to the frozen pellet.

    2.The tissue homogenizer should be cleaned so that it is RNase-free. At a minimum will require immersion and homogenization in ddH2 O and ethanol 3 times sequentially, may require boiling H2 O, SDS, or 10% bleach in addition. An RNAse degrader such as RNAse Zap can also be used.

    3.Shear each sample with a 3-5 second run of the tissue homogenizer, essentially until the cell pellet is no longer visible. Clean homogenizer tip between runs.

    4.Incubate the sheared samples in Lysis Buffer at 45℃ for 45 minutes.

    5.Add 950 μl 5M NaCl stock solution and mix.

    6.Shear DNA using a 21 gauge needle attached to a sterile 20cc syringe. This step involves drawing the lysate into the syringe through the needle and expelling it from the syringe, again through the needle. This step should be repeated 3 times.

    7.Add one tube of oligo(dT) cellulose to each sample.

    8.Incubate for 2 minutes at room temperature. Vortex the sample to resuspend the cellulose completely.

    9.Rock the tube gently in a horizontal position for 60-90 minutes at room temperature.

    10.Centrifuge the oligo(dT) slurry at 3,000 x g for 5 minutes at room temperature. Make sure the brake on the centrifuge is set at low for all centrifugation steps, as a high brake may disturb the pellet.

    11.Carefully aspirate and discard the supernatant, trying not to disturb the easily dispersed pellet.

    Washing Oligo(dT) Cellulose

    1.Resuspend oligo(dT) in 20ml Binding Buffer by vortexing.

    2.Centrifuge at 3,000 x g for 5 minutes at room temperature.

    3.Resuspend oligo(dT) in 10ml Binding Buffer by vortexing.

    4.Centrifuge at 3,000 x g for 5 minutes at room temperature.

    5.Resuspend oligo(dT) in 10ml Low Salt Wash Buffer by vortexing.

    6.Centrifuge at 3,000 x g for 5 minutes at room temperature.

    7.Repeat Low Salt Wash Buffer wash two more times.

    8.Resuspend oligo(dT) in 800μl Low Salt Wash Buffer using a 1-2ml serological pipette.

    9.Transfer about 800μl of the oligo(dT) slurry to a spin column seated in the included microcentrifuge tube.

    101Centrifuge at 5,000 x g for 10 seconds at room temperature.

    11.Aspirate and discard the flow-through liquid in the microcentrifuge tube.

    12.Repeat the transfer and centrifugation steps until ALL of the oligo(dT) cellulose is in the spin column.

    Elution and Precipitation of the mRNA

    1.Place the spin column containing the oligo(dT) into one of the included clean microcentrifuge tubes.

    2.Heat elution buffer to 65℃ in a bath (or about 10-15 seconds in a microwave).

    3.Resuspend the oligo(dT) in 200μl Elution Buffer (heated), using the pipette tip to gently swirl the cellulose, without puncturing the underlying spin column membrane.

    4.Centrifuge at 5,000 x g for 30 seconds at room temperature. Do not decant. Keep the eluent, it contains your mRNA.

    5.Again resuspend the oligo(dT) in 200μl Elution Buffer (heated).

    6.Centrifuge at 5,000 x g for 30 seconds at room temperature.

    7.Save the combined 400μl eluent in the microcentrifuge tube.

    8.Add 60μl of 2M sodium acetate and mix.

    9.Add 1ml of 95% ethanol (Do not use 100% ethanol, it contains fluorescent contaminants).

    10.Freeze at -70℃ overnight.

    11.Thaw and centrifuge at 16,000 x g for 15 minutes at 4℃.

    12.Carefully aspirate all the ethanol from the mRNA pellet, taking care not to disturb the pellet.

    13.Resuspend the mRNA pellet in 20μl of Elution Buffer (heated as before).

    14.Determine the concentration of the mRNA by OD or "eyeballing" on an agarose minigel.

    15.Store mRNA at -70℃.

    16.The standard FastTrack protocol can be found on the Invitrogen website here.


    相關文章

    mRNA霧化治療矽肺見效,小鼠實驗肺功能得到明顯改善

    近日,西安交通大學第二附屬醫院(以下簡稱西安交大二附院)胸外科副研究員李建忠和助理研究員田運澤與國內科研團隊合作,通過霧化吸入的方式高效遞送TBX2mRNA,顯著改善了矽肺小鼠的肺纖維化和肺功能,為矽......

    科學家實現mRNA體內精準靶向遞送

    近日,中國科學院國家納米科學中心成功創建了一種基于脂質空間構象的人工智能(AI)全新模型,通過精準解析可電離脂質的三維空間構象,成功攻克了脂質納米顆粒(LNP)在mRNA藥物遞送中存在的轉染效率低下與......

    mRNA疫苗遞送研究取得進展

    mRNA疫苗進入人體后極易被降解,因此必須借助脂質納米顆粒(LNP)作為“運輸工具”。但傳統LNP存在一些問題:一方面,它們在體內的真實去向并不清楚;另一方面,大量載體會被肝臟“誤捕獲”,既降低了靶組......

    mRNA“戴帽”后能多產兩百倍蛋白質

    日本名古屋大學研究團隊在最新一期《自然·生物技術》雜志上發表了一項名為“內部帽啟動翻譯”(ICIT)機制的創新研究。該機制下的仿佛戴著帽子的mRNA可產生200倍以上的蛋白質,為治療癌癥和蛋白質合成異......

    科研人員開發出高效植物mRNA遞送系統

    基因組編輯技術在農業領域的應用推動了作物改良,但以DNA形式遞送基因編輯工具的方式存在外源DNA整合風險和脫靶效應。近年來,無外源DNA殘留的基因組編輯遞送技術備受關注。盡管基于核糖核蛋白的遞送策略在......

    mRNA技術有望治療先兆子癇

    一種mRNA療法在小鼠身上的成功試驗,為治療常見妊娠并發癥——先兆子癇帶來希望。近日,相關論文發表于《自然》。高血壓是子癇前期的常見癥狀。圖片來源:NataliyaPiatrovich/Alamy在可......

    GSK公司|季節性流感mRNA疫苗2期臨床試驗結果積極

    2024年4月,葛蘭素史克(GSK)在一項2期臨床試驗中證實,其候選mRNA流感疫苗在預防甲型流感方面戰勝了已獲批的滅活流感疫苗,但對于“歷史性難題”乙型流感方面未能達到同樣的效果。與GSK合作研發該......

    定制mRNA載體可快速創建并自帶“導航”

    7月11日,美國賓夕法尼亞大學研究團隊利用“點擊化學”技術,通過一個簡單步驟創建出脂質納米顆粒(LNP)。發表在最新一期《自然·化學》雜志上的這項研究表明,其不僅加快了合成過程,還提供了一種為這些輸送......

    定制mRNA載體可快速創建并自帶“導航”

    脂質納米顆粒是最先進的藥物輸送平臺之一,可以運送mRNA。圖片來源:penntoday網站科技日報北京7月11日電(記者張夢然)美國賓夕法尼亞大學研究團隊利用“點擊化學”技術,通過一個簡單步驟創建出脂......

    Nature子刊:劉帥/顧臻/平淵團隊設計三組分LNP,實現器官靶向的mRNA積累和翻譯

    mRNA療法在治療多種蛋白質相關疾病方面已展現出巨大潛力,其潛在應用與靶向給藥技術的進步密切相關。真正的靶向需要在特定器官中同時發生mRNA的積累和翻譯,以實現治療功能并將副作用降至最低.然而,現有的......

  • <table id="4yyaw"><kbd id="4yyaw"></kbd></table>
  • <td id="4yyaw"></td>
  • 调性视频